M
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Price:
121.2
SAR
1.68%
Market Closed
Market Cap:
﷼2.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
|
SA |
|
N
|
Netstars Co Ltd
TSE:5590
|
JP |
|
Zhixin Group Holding Ltd
HKEX:2187
|
CN |
|
A
|
AngloGold Ashanti Ltd
XBER:AOD1
|
ZA |
|
LONGi Green Energy Technology Co Ltd
SSE:601012
|
CN |
|
Kitazawa Sangyo Co Ltd
TSE:9930
|
JP |
|
Cadeler A/S
OSE:CADLR
|
DK |
|
Kisoji Co Ltd
TSE:8160
|
JP |
|
Westlake Corp
NYSE:WLK
|
US |
|
S
|
Sapiens International Corporation NV
TASE:SPNS
|
IL |
|
Cashlez Worldwide Indonesia Tbk PT
IDX:CASH
|
ID |
|
Target Corp
NYSE:TGT
|
US |
|
Jiangsu King's Luck Brewery Joint-Stock Co Ltd
SSE:603369
|
CN |
|
K
|
Kap Industrial Holdings Ltd
JSE:KAP
|
ZA |
|
J
|
JSR Corp
SWB:JYR
|
JP |
|
Ming Yuan Cloud Group Holdings Ltd
HKEX:909
|
CN |
Income Statement
Earnings Waterfall
Middle East Pharmaceutical Industries Company SJSC
Middle East Pharmaceutical Industries Company SJSC
Income Statement
Middle East Pharmaceutical Industries Company SJSC
Middle East Pharmaceutical Industries Company SJSC
Currency: SAR
| Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Interest Expense |
6
|
4
|
4
|
5
|
4
|
0
|
0
|
0
|
0
|
|
| Revenue |
338
N/A
|
508
+50%
|
515
+2%
|
596
+16%
|
394
-34%
|
416
+5%
|
432
+4%
|
459
+6%
|
460
+0%
|
|
| Gross Profit | ||||||||||
| Cost of Revenue |
(134)
|
(201)
|
(197)
|
(232)
|
(151)
|
(158)
|
(166)
|
(177)
|
(174)
|
|
| Gross Profit |
204
N/A
|
306
+50%
|
318
+4%
|
365
+15%
|
243
-33%
|
257
+6%
|
266
+4%
|
282
+6%
|
287
+2%
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(126)
|
(195)
|
(203)
|
(243)
|
(152)
|
(156)
|
(162)
|
(173)
|
(178)
|
|
| Selling, General & Administrative |
(121)
|
(183)
|
(190)
|
(228)
|
(149)
|
(153)
|
(160)
|
(172)
|
(173)
|
|
| Depreciation & Amortization |
(4)
|
(12)
|
(12)
|
(15)
|
(5)
|
(7)
|
(6)
|
(5)
|
(6)
|
|
| Other Operating Expenses |
(0)
|
(1)
|
(1)
|
(0)
|
1
|
4
|
4
|
4
|
(0)
|
|
| Operating Income |
78
N/A
|
111
+42%
|
115
+3%
|
122
+6%
|
91
-25%
|
101
+11%
|
105
+4%
|
109
+4%
|
108
0%
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
(6)
|
(8)
|
(8)
|
(8)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
71
N/A
|
102
+43%
|
106
+4%
|
111
+5%
|
86
-22%
|
96
+12%
|
100
+4%
|
104
+4%
|
104
0%
|
|
| Net Income | ||||||||||
| Tax Provision |
(6)
|
(9)
|
(9)
|
(10)
|
(7)
|
(6)
|
(7)
|
(7)
|
(7)
|
|
| Income from Continuing Operations |
66
|
93
|
97
|
101
|
80
|
90
|
93
|
97
|
97
|
|
| Net Income (Common) |
66
N/A
|
93
+42%
|
97
+4%
|
101
+4%
|
80
-21%
|
90
+13%
|
93
+3%
|
97
+5%
|
97
0%
|
|
| EPS (Diluted) |
3.29
N/A
|
4.66
+42%
|
4.85
+4%
|
5.04
+4%
|
3.99
-21%
|
4.49
+13%
|
4.64
+3%
|
4.86
+5%
|
4.85
0%
|
|
Switch to:
Switch to:
See Also
Discover More
